Tone mix
Week by week 52 weeks
Share of Ensysce Biosciences, Inc. Common Stock's 127 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 18, 2025 · tone -100Q3 EPS Estimate for Ensysce Biosciences Lowered by Analyst-144
- Week of Mar 10, 2025 · tone -75Ensysce Biosciences (NASDAQ:ENSC) Releases Earnings Results, Misses Expectations By $0.16 EPS-85
- Week of Apr 13, 2026 · tone +100Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study+80
- Week of Apr 14, 2025 · tone +67Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection ...+67
- Week of Jan 6, 2025 · tone 0Ensysce Biosciences Issues Annual Shareholder Letter-64
- Week of Dec 29, 2025 · tone 0Ensysce Biosciences, Inc. (NASDAQ:ENSC) Sees Large Increase in Short Interest-63
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Ensysce Biosciences, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +38 |
| Last 30 sessions | 8 | +19 |
| Last 90 sessions | 35 | +41 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletReviewing Ensysce Biosciences (NASDAQ:ENSC) and Axsome Therapeutics (NASDAQ:AXSM)Neutral
- www.dailypolitical.com · 1 outletReviewing Axsome Therapeutics (NASDAQ:AXSM) and Ensysce Biosciences (NASDAQ:ENSC)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Reviewing Ensysce Biosciences (NASDAQ:ENSC) and Axsome Therapeutics (NASDAQ:AXSM) | www.tickerreport.com | 1 | Neutral |
| Reviewing Axsome Therapeutics (NASDAQ:AXSM) and Ensysce Biosciences (NASDAQ:ENSC) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
2 headlines, average tone +76: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.pr-inside.com · 1 outletEnsysce Biosciences Expands Global Investor and Strategic Outreach ...Positive
- www.finanznachrichten.de · 1 outletEnsysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, DubaiPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ensysce Biosciences Expands Global Investor and Strategic Outreach ... | www.pr-inside.com | 1 | Positive |
| Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletEnsysce Biosciences (NASDAQ:ENSC) Now Covered by Cantor FitzgeraldNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ensysce Biosciences (NASDAQ:ENSC) Now Covered by Cantor Fitzgerald | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, September 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletEnsysce Biosciences (NASDAQ:ENSC) versus Silo Pharma (NASDAQ:SILO) Head-To-Head ReviewNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ensysce Biosciences (NASDAQ:ENSC) versus Silo Pharma (NASDAQ:SILO) Head-To-Head Review | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, September 25, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.californiatelegraph.com · 3 outletsEnsysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPSNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS | www.californiatelegraph.com | 3 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Ensysce Biosciences, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.